Internal Medicine, Hematology & Oncology · Brooklyn, NY
NPI
1639129026
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3364 Nostrand Ave
Brooklyn, NY, 11229
Phone (347) 570-5348
Groups this clinician bills Medicare through
Medicare paid, 2024
$613K
15,465 services
Medicare patients, 2024
570
Average age 79
Drug cost, 2024
$8.7M
17,079 prescriptions
Company payments, 2025
$2,791
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irena Pleskova was code 99490 (chronic, principal, and transitional care management), 2,657 times for 328 patients. In total Irena Pleskova billed 15,465 services in 81 codes, and Medicare paid $613K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,657 | 328 | $54.86 | $146K |
| 99454 E&M - Miscellaneous | Office | 2,563 | 317 | $43.67 | $112K |
| 99457 E&M - Miscellaneous | Office | 2,562 | 317 | $43.88 | $112K |
| 99213 Office E&M - Established | Office | 1,414 | 442 | $79.03 | $112K |
| 36415 Venipuncture Blood Collection | Office | 784 | 225 | $8.65 | $6,782 |
| 93000 Electrocardiogram | Office | 732 | 218 | $12.77 | $9,351 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 595 | 13 | $1.69 | $1,005 |
| 99214 Office E&M - Established | Office | 477 | 184 | $114.35 | $55K |
| 96372 Injection Administration | Office | 415 | 115 | $12.79 | $5,309 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 413 | 13 | $0.37 | $151 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 265 | 104 | $0.98 | $260 |
| 96365 Intravenous Infusion, Hydration | Office | 226 | 47 | $58.08 | $13K |
| 99212 Office E&M - Established | Office | 218 | 88 | $50.43 | $11K |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 213 | 50 | $1.03 | $219 |
| J0897 Injection, denosumab, 1 mg | Office | 90 | 16 | $20.80 | $1,872 |
By year: 2022 $803K for 22,791 services; 2023 $669K for 18,628 services; 2024 $613K for 15,465 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 784 | 225 | $8.65 | $6,782 |
| 81002 Clinical Chemistry | 19 | 14 | $3.41 | $64.79 |
Medicare prescription drug claims, 2024
In 2024, the drug Irena Pleskova prescribed most often to Medicare patients was Zenpep (Lipase/Protease/Amylase), with 596 prescriptions and refills. In total Irena Pleskova wrote 17,079 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zenpep Lipase/Protease/Amylase | 596 | 938 | 132 | $1.3M |
| Rosuvastatin Calcium Generic | 417 | 777 | 105 | $4,251 |
| Entresto Sacubitril/Valsartan | 408 | 590 | 72 | $384K |
| Linzess Linaclotide | 386 | 525 | 70 | $273K |
| Vascepa Icosapent Ethyl | 371 | 551 | 81 | $189K |
| Metoprolol Succinate Generic | 330 | 590 | 74 | $3,950 |
| Diclofenac Sodium Generic | 326 | 437 | 69 | $219K |
| Amlodipine Besylate Generic | 317 | 536 | 82 | $1,075 |
| Eliquis Apixaban | 307 | 454 | 57 | $270K |
| Omeprazole Generic | 249 | 443 | 70 | $1,389 |
| Ranolazine Er Ranolazine | 248 | 386 | 50 | $12K |
| Carvedilol Generic | 240 | 424 | 52 | $1,147 |
| Pitavastatin Calcium Generic | 228 | 485 | 64 | $71K |
| Clopidogrel Clopidogrel Bisulfate | 227 | 388 | 50 | $1,271 |
| Repatha Sureclick Evolocumab | 221 | 225 | 26 | $119K |
Brand drugs: 6,349 claims; generic drugs: 10,540 claims; opioid claims: 127.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irena Pleskova $2,791 ($2,791 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $642.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $642 |
| Sumitomo Pharma America, Inc. 4506.T | 13 | $231 |
| Axsome Therapeutics, Inc. AXSM | 9 | $207 |
| Amgen Inc. AMGN | 13 | $205 |
| Merck Sharp & Dohme LLC MRK | 9 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $169 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $149 |
| Aimmune Therapeutics, Inc. | 5 | $134 |
| Azurity Pharmaceuticals, Inc. | 6 | $125 |
| Paratek Pharmaceuticals, Inc. | 6 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.